Home LiteratureArticle Details
PMID: 3434218 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Diffuse Lewy body disease. Neuropathological and biochemical studies of six patients.

Acta neuropathologica ·Vol. 75 ·No. 1 ·1987-00-00 ·Pages 8-15

Dickson DW, Davies P, Mayeux R, Crystal H, Horoupian DS, Thompson A, Goldman JE

Abstract

Post-mortem pathological and biochemical studies are reported on six patients with progressive dementia. The characteristic pathological finding was neurofilament-containing cytoplasmic inclusions in cortical and subcortical neurons. The clinical and pathological findings were consistent with so-called diffuse Lewy body disease. The patients had variable changes of the Alzheimer type, with five of six patients displaying "plaques only" Alzheimer's changes. Biochemical studies showed profound decreases in neocortical choline acetyltransferase (ChAT) activities that correlated with marked neuronal loss in the basal nucleus of Meynert. ChAT activities were normal in the hippocampus in three patients who also had no significant Alzheimer type hippocampal changes. All patients had decreased cortical somatostatin-like immunoreactivity. Our observations suggest that dementia in diffuse Lewy body disease bears biochemical similarities to Alzheimer's disease, in that biochemical markers for both intrinsic cortical neurons and ascending cholinergic neurons are affected.

MeSH Terms
Aged Atrophy Brain/pathology Cytoplasmic Granules/ultrastructure Dementia/pathology,physiopathology,psychology Humans Neurons/cytology Organ Specificity
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Dickson D W
Department of Pathology (Neuropathology), Rose F. Kennedy Center for Research in Mental Retardation and Human Development, Bronx, NY 10461.
Davies P
Mayeux R
Crystal H
Horoupian D S
Thompson A
Goldman J E
References (36)
36 references, click to expand
  1. Selective loss of central cholinergic neurons in Alzheimer's disease.
    Lancet. 1976 Dec 25;2(8000):1403 PMID: 63862
  2. Pathologic correlates of dementia in Parkinson's disease.
    Arch Neurol. 1986 Oct;43(10):991-5 PMID: 3753274
  3. Widespread reduction of somatostatin-like immunoreactivity in the cerebral cortex in Alzheimer's disease.
    Ann Neurol. 1986 Oct;20(4):489-95 PMID: 3789664
  4. Basal forebrain neurons in the dementia of Parkinson disease.
    Ann Neurol. 1983 Mar;13(3):243-8 PMID: 6847136
  5. Two monoclonal antibodies recognize Alzheimer's neurofibrillary tangles, neurofilament, and microtubule-associated proteins.
    J Neurochem. 1987 Feb;48(2):455-62 PMID: 2432180
  6. Ballooned neurons in select neurodegenerative diseases contain phosphorylated neurofilament epitopes.
    Acta Neuropathol. 1986;71(3-4):216-23 PMID: 2432750
  7. Parkinson's disease: neuron loss in the nucleus basalis without concomitant Alzheimer's disease.
    Ann Neurol. 1984 May;15(5):415-8 PMID: 6732189
  8. Dementia and Parkinson's disease associated with diffuse cortical Lewy bodies.
    Lancet. 1987 Feb 28;1(8531):501 PMID: 2881052
  9. The nucleus basalis of Meynert.
    Can J Neurol Sci. 1986 Feb;13(1):8-14 PMID: 2937514
  10. Parkinson's disease in patients with Alzheimer's disease.
    Arch Neurol. 1986 Jul;43(7):662-4 PMID: 3729742
  11. Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadriparesis in flexion.
    J Neuropathol Exp Neurol. 1961 Apr;20:237-44 PMID: 13730588
  12. Alzheimer changes in nondemented patients younger than sixty-five: possible early stages of Alzheimer's disease and senile dementia of Alzheimer type.
    Ann Neurol. 1985 Mar;17(3):273-7 PMID: 3994315
  13. Reaction of Lewy bodies with antibodies to phosphorylated and non-phosphorylated neurofilaments.
    Neurosci Lett. 1986 Mar 14;64(3):253-8 PMID: 2421208
  14. A neuronal antigen in the brains of Alzheimer patients.
    Science. 1986 May 2;232(4750):648-50 PMID: 3083509
  15. Idiopathic Parkinsonism with Lewy-type inclusions in cerebral cortex. A case report.
    Acta Neuropathol. 1978 Feb 20;41(2):165-8 PMID: 205083
  16. Acetylcholinesterase-rich projections from the basal forebrain of the rhesus monkey to neocortex.
    Brain Res. 1976 Jun 4;109(1):152-7 PMID: 819100
  17. Neuropeptides in aging and dementia.
    Peptides. 1984;5 Suppl 1:269-74 PMID: 6148737
  18. Immunohistochemical distribution of pro-somatostatin-related peptides in cerebral cortex.
    Brain Res. 1983 Mar 7;262(2):344-51 PMID: 6132664
  19. Senile dementia of the Alzheimer type without neocortical neurofibrillary tangles.
    J Neuropathol Exp Neurol. 1987 May;46(3):262-8 PMID: 2881985
  20. Lewy body dementia without Alzheimer changes.
    Can J Neurol Sci. 1986 Nov;13(4 Suppl):490-7 PMID: 3024794
  21. Somatostatin and dementia in Parkinson's disease.
    Brain Res. 1983 Nov 14;278(1-2):376-9 PMID: 6139152
  22. Neurotransmitter-related enzymes in senile dementia of the Alzheimer type.
    Brain Res. 1979 Aug 3;171(2):319-27 PMID: 37989
  23. A new definition of Alzheimer's disease: a hippocampal dementia.
    Lancet. 1985 Jan 5;1(8419):14-6 PMID: 2856948
  24. Amyloid degeneration and tuberculosis in the aged.
    Gerontologia. 1972;18(5-6):321-62 PMID: 4680735
  25. Cortical cholinergic deficit in mentally impaired Parkinsonian patients.
    Lancet. 1983 Oct 1;2(8353):789-90 PMID: 6137620
  26. Parkinson's disease: distribution of Lewy bodies and monoamine neuron system.
    Acta Neuropathol. 1976 Apr 26;34(4):311-9 PMID: 179263
  27. Somatostatin immunoreactivity is reduced in Parkinson's disease dementia with Alzheimer's changes.
    Brain Res. 1986 Nov 12;397(2):386-8 PMID: 3801878
  28. Somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with Parkinson's disease and its relation to dementia.
    J Neurol Neurosurg Psychiatry. 1986 Dec;49(12):1374-7 PMID: 2433403
  29. Somatostatin is not co-localized in cholinergic neurons innervating the rat cerebral cortex-hippocampal formation.
    Brain Res. 1982 Jul 8;243(1):169-72 PMID: 6126255
  30. Cortical changes in the parkinsonian brain: a contribution to the delineation of "diffuse Lewy body disease".
    J Neurol. 1983;229(1):17-32 PMID: 6189974
  31. Lewy bodies of Parkinson's disease contain neurofilament antigens.
    Science. 1983 Sep 9;221(4615):1082-4 PMID: 6308771
  32. Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree--a new disease?
    Clin Neuropathol. 1984 Sep-Oct;3(5):185-92 PMID: 6094067
  33. Cortical somatostatin-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type.
    Neurobiol Aging. 1981 Spring;2(1):9-14 PMID: 6115327
  34. Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities.
    J Neurol Sci. 1982 Dec;57(2-3):407-17 PMID: 7161627
  35. The morphological basis of dementia in Parkinson's disease.
    Can J Neurol Sci. 1984 Feb;11(1 Suppl):180-4 PMID: 6713315
  36. Dementia in idiopathic Parkinson's disease. A neuropathological study of 32 cases.
    Acta Neuropathol. 1984;64(1):43-52 PMID: 6089493
Article Info
Journal
Acta neuropathologica
Abbr.
Acta Neuropathol
ISSN
0001-6322
Published
1987-00-00
Pages
8-15
Language
English
Region
Germany
NLM ID
0412041
Subset
IM
Grants
NIMH NIH HHS · MH38263 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]